Kyndryl (NYSE: KD), a leading provider of mission-critical enterprise technology services, today announced an expansion of its global strategic alliance with HPE to deliver services that enable and support customer adoption of HPE Private Cloud AI, a turnkey enterprise AI factory solution co-developed with NVIDIA. https://mma.prnewswire.com/media/1756212/Kyndryl_Logo_v1.jpg As part of the expanded collaboration, Kyndryl Consult will […]

New research confirms the accuracy of citizen science reports in mapping whale populations See Photos here. VANCOUVER, British Columbia, Aug. 06, 2025 (GLOBE NEWSWIRE) — A new study from Ocean Wise confirms just how powerful citizen science can be. Assessing Cetacean Habitat Suitability in the Northeast Pacific From Citizen Science Data, published in the Journal

(NYSE:PFS), ISELIN, N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) — Provident Bank, a leading New Jersey-based financial institution, has announced that Michael A. Perito has joined the organization as Senior Vice President and Head of Corporate Strategy. In this newly created role, Mr. Perito will be responsible for overseeing the development and execution of the bank's

(Other OTC:GAMI),(OTC US:GAMI),(NasdaqGM:AIRO),(NASDAQ:ESLT),(NYSE:AIN),(NYSE:GHM),(NYSE:HEI),(NASDAQ:ATRO),(NYSE:MOG-A),(NASDAQ:HOVR),(NasdaqGM:BAER),(NYSE:RDW),(NYSE:CR),(XETRA:RHM),(NYSE:CW),(NYSE:SARO),(NasdaqGM:TATT),(NYSE:TXT),(NYSE:DCO),(AUST:DRO.AX),(AUST:DRO),(National Stock Exchange:DCXINDIA),(National Stock Exchange:DCXINDIA.NS),(Milan:AVIO), GREENWICH, Conn., Aug. 06, 2025 (GLOBE NEWSWIRE) — Gabelli Funds, LLC, is hosting our annual Aerospace & Defense Symposium at The Harvard Club in New York City on September 4th. The conference will draw top executives from more than ten companies, with a focus on the themes of

(NasdaqGM:MRUS), UTRECHT, The Netherlands and CAMBRIDGE, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS), an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates (Biclonics(R), Triclonics(R) and ADClonics(R)), today announced that Bill Lundberg, M.D., President, Chief Executive Officer of Merus, will participate in a fireside chat at the Canaccord Genuity

(NASDAQ:MRSN), CAMBRIDGE, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that it will provide business updates and report its financial results for the second quarter ended June 30,

(Other OTC:AONC),(OTC US:AONC), HOT SPRINGS, Ark., Aug. 06, 2025 (GLOBE NEWSWIRE) — Genesis Cancer and Blood Institute, a partner practice of American Oncology Network (AON), is pleased to welcome Board-certified physician Tyler Fugere, MD, to its physician care team. She joins an experienced group of physicians including Drs. Brad Baltz, Jim Chen, Timothy Webb, Robert

(NASDAQ:LRE), TOKYO, Aug. 06, 2025 (GLOBE NEWSWIRE) — Lead Real Estate Co., Ltd (Nasdaq: LRE) (“LRE” or “the Company”), a Japanese real estate developer of luxury residential properties including single-family homes and condominiums across Tokyo, Kanagawa Prefecture and Sapporo, is announcing the official start of the “Master Lease Business” and the sale of the hotel

(NASDAQ:KALA), ARLINGTON, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) — KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today announced that members of management will present at the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference being held virtually

(PinkSheets:NKGN),(Pinksheets:NKGN), SANTA ANA, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) — NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell therapeutics, today announced that Paul Y. Song, M.D., Chairman and Chief Executive Officer of NKGen, will present